TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 196 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $34,000 | +142.9% | 447 | -10.2% | 0.00% | – |
| Q1 2022 | $14,000 | -65.0% | 498 | -40.2% | 0.00% | – |
| Q4 2021 | $40,000 | -16.7% | 833 | +15.1% | 0.00% | – |
| Q3 2021 | $48,000 | -9.4% | 724 | +5.7% | 0.00% | – |
| Q2 2021 | $53,000 | -14.5% | 685 | +3.2% | 0.00% | – |
| Q1 2021 | $62,000 | +10.7% | 664 | +45.3% | 0.00% | – |
| Q4 2020 | $56,000 | +100.0% | 457 | +46.0% | 0.00% | – |
| Q3 2020 | $28,000 | +115.4% | 313 | +51.9% | 0.00% | – |
| Q2 2020 | $13,000 | +1200.0% | 206 | +1044.4% | 0.00% | – |
| Q1 2020 | $1,000 | – | 18 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |